A Merck Canada poll flags a plan-communication gap
Nearly one-third of Canadians surveyed say their private insurance covers vaccines, but they do not know which ones. The finding comes from a new poll that also shows gaps in adult immunization.
The Merck Canada Pulse Report, conducted by Ipsos, was released Tuesday. Merck, which makes vaccines, commissioned the survey,.
For benefits and pensions professionals, the 31% figure suggests plan communication may matter as much as plan design.
Fewer adults say they are up to date
Among parents or legal guardians, 84% said their children are fully up to date on recommended vaccines. Adults reported lower rates.
- Adults aged 65 to 75: 51% said they are fully up to date.
- Adults aged 18 to 64: 33% said the same.
The release says recommendations vary by age, health conditions, travel plans and work environments. Questions about coverage add another layer of complexity.
Ipsos surveyed 1,000 Canadians aged 18 and older online between Aug. 20 and 25. It says the poll is accurate to within 3.8 percentage points, 19 times out of 20. The margin is wider for subgroups.
Healthcare professionals were the top source of vaccine information, at 79%. More than half (54%) look online, rising to 62% among adults aged 18 to 34.
Four in 10 said clearer explanations of why vaccines are recommended at certain ages would raise their confidence. Another 62% said they are likely or somewhat likely to raise immunization schedules with a doctor, pharmacist or nurse practitioner within 12 months.
"It's encouraging to see that Canadians recognize the value of vaccination," said Dr. Victor Leung, an infectious diseases physician and medical microbiologist at Providence Health Care. "At the same time, adult immunization is an area where some people may benefit from additional information and support. Vaccine recommendations can change over time, and conversations with trusted healthcare professionals can help Canadians understand what is recommended for them based on their age, health status, coverage, and individual circumstances."
"Canadians should feel empowered to ask questions and understand what recommendations and options are relevant to them," Matthew Thornhill, executive director of Merck Canada's vaccines and HIV business unit, said. "Creating more opportunities for these discussions and supporting greater access to qualified healthcare providers can help bring trusted immunization guidance and services closer to Canadians in their communities."
What it means for plan sponsors
Other data shows coverage is uneven.
A Mapol report card, cited in a July opinion column, found 71% of plan members have coverage for recommended adult vaccines. That leaves nearly one in three without it.
Frédéric Leblanc of iA Financial Group wrote that group drug plans often treat prevention as optional. He urged sponsors to explain coverage clearly, including for dependents.
Uptake is also a concern in public data. About 34% of adults received a flu shot in 2025-26, Public Health Agency of Canada data show. That was down from 44% three seasons earlier.
Pharmacist Ajit Sohal told Benefits and Pensions Monitor in 2025 that sponsors long assumed governments cover vaccines. He said most provinces do not fund the shingles vaccine for working adults.
Plan sponsors and advisers could use the findings in three ways:
- Review which recommended vaccines the plan covers, and which provinces fund.
- Test whether members can find that information easily.
- Consider pharmacy access or seasonal reminders.
Because the survey was self-reported and commissioned by a company that makes vaccines, its figures are best read as indicators.


